Author: Jenny Lu

11 Jan

Posted at 16:22h in Patients/Healthcare Providers, Update by
0 Likes

All TreatGx users now have access to the updated algorithms for Chronic Gout and Prevention of Non-Steroidal Anti-Inflammatory (NSAID)-Induced Gastrotoxicity.  Chronic Gout:  This comprehensive update incorporates information from the most recent clinical guidelines and literature, including updates from the American College of Rheumatology [1], BMJ Best Practice [2], and the European League Against Rheumatism [3].   New information about pharmacogenetic testing for select populations before starting...

08 Dec

Posted at 17:39h in Patients/Healthcare Providers, Update by
0 Likes

All TreatGx users now have access to the updated Generalized Anxiety Disorder treatment algorithm. This comprehensive update incorporates information from the most recent clinical guidelines and literature from the American Family Physician[1], the BMJ[2], Lancet[3], and others. Highlights of the update include: 8 new medication treatment options that have been added based on the latest evidence...

08 Dec

Posted at 17:01h in New Condition, Patients/Healthcare Providers by
0 Likes

We are pleased to announce the addition of Atrial Fibrillation - Rhythm Control to our TreatGx medication decision support software. The Atrial Fibrillation - Rhythm Control algorithm can now be accessed by all TreatGx users. This algorithm provides long term medication treatment options for the maintenance of sinus rhythm in...

30 Oct

Posted at 13:42h in Patients/Healthcare Providers, Update by
0 Likes

TreatGx users now have access to the updated Chronic Pain – Low Back Pain treatment algorithm. A key feature of this update is being able to view all medication options at-a-glance. In addition to displaying personalized dosing options based on kidney function, liver function, drug-drug interactions, medical history, and pharmacogenetics (whether available or not), and continuing to provide guidance on gastroprotection in patients at high...

05 Aug

Posted at 14:05h in New Condition, Patients/Healthcare Providers by
0 Likes

We are pleased to announce the addition of two new conditions to our TreatGx medication decision support system. Alzheimer’s Disease and Insomnia can now be accessed by all TreatGx users.   The Alzheimer’s algorithm provides treatment options for adults with mild, moderate, or severe Alzheimer’s disease, and includes guidance on medication titration and switching. Treatment options and dosing are based on the most up-to-date...